Physician profile
Christian Smith
NPI 1366079493
$836.95
in general payments reported to CMS, 2019-2025
10 companies · $406 in 2025
The $406 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $19.71 · 2024: $411 · 2025: $406.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $837.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $836.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanara Medtech INC. | $414.04 | 2024-2025 | Celleraterx, Celleraterx |
| Gentleman Orthopedic Solutions | $85.28 | 2025 | |
| Mimedx Group, INC. | $81.24 | 2024-2025 | |
| Active Medical, LLC | $70.20 | 2024 | |
| Orthofix Medical, INC. | $57.20 | 2023-2025 | Physio-Stim, Truelok, Tl-Hex Truelok Hexapod System |
| Paragon 28, INC. | $45.20 | 2025 | Gorilla, Precision Mis Bunion |
| Stryker Corporation | $30.77 | 2024-2025 | Easyfuse, Ortholoc 2 Lapifuse, Prostep Mica |
| Smith+Nephew, INC. | $21.78 | 2025 | Grafix Pl |
| Treace Medical Concepts, INC. | $15.81 | 2025 | |
| Solventum Corporation | $15.43 | 2024 | Activ.A.C., Snap |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christian Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.